Product: Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01
Reason for recall: Failed Dissolution Specifications
Recall initiated: 20210823
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated